GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company who has developed and commercialized an intradermal needle-free platform to more effectively administer drugs and biologics, today announced that ...

The PharmaJet Tropis Intradermal (ID) Needle-free Injection System will be used to deliver approximately 1.4 million polio vaccine doses in a Nigerian campaign. To date, supplies for more than 20 ...

First self-administered, needle-free injection system approved by Health Canada gives access to safe, painless, cost-effective, and more sustainable drug delivery for chronic illnesses Toronto, ...

Growth in Needle-Free Injection System market. Market Dynamics. Some key players. The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company who has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced that they will ...

Toronto, Ontario--(Newsfile Corp. - August 21, 2025) - NuGen Medical Devices Inc. (NGMD:CA) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to ...

PharmaJet’s Needle-free intradermal (ID) injection device (“Tropis ® ID”) will be evaluated as delivery system for the tuberculin skin test (TST) in a clinical study conducted by REDE-TB. The study ...

PharmaJet, a global leader in needle-free injection technology, today announced that its WHO-prequalified Tropis ID Needle-free Injection System will be used to deliver approximately 1.4 million doses ...